Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
2005 |
| gptkbp:associatedWith |
gptkb:Viagra
|
| gptkbp:ATCCode |
gptkb:G04BE03
|
| gptkbp:brand |
gptkb:sildenafil
|
| gptkbp:CASNumber |
139755-83-2
|
| gptkbp:chemicalFormula |
C22H30N6O4S
|
| gptkbp:contraindication |
concurrent nitrate therapy
|
| gptkbp:eliminationHalfLife |
3-5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Revatio
|
| gptkbp:indication |
improving exercise ability in adults with pulmonary arterial hypertension
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
phosphodiesterase type 5 inhibitor
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
headache
nasal congestion dyspepsia flushing |
| gptkbp:usedFor |
pulmonary arterial hypertension
|
| gptkbp:bfsParent |
gptkb:Viagra
|
| gptkbp:bfsLayer |
5
|